<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 https://raw.githubusercontent.com/kermitt2/grobid/master/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main">Redox factor-1 in muscle biopsies of patients with inclusion-body myositis</title>
			</titleStmt>
			<publicationStmt>
				<publisher/>
				<availability status="unknown"><licence/></availability>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author>
							<persName><forename type="first">Aldobrando</forename><surname>Broccolini</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Department of Neurology</orgName>
								<orgName type="institution" key="instit1">USC Neuromuscular Center</orgName>
								<orgName type="institution" key="instit2">University of Southern California Keck School of Medicine</orgName>
								<orgName type="institution" key="instit3">Good Samaritan Hospital</orgName>
								<address>
									<postCode>90017-1912</postCode>
									<settlement>Los Angeles</settlement>
									<region>CA</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">W</forename><surname>King Engel</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Department of Neurology</orgName>
								<orgName type="institution" key="instit1">USC Neuromuscular Center</orgName>
								<orgName type="institution" key="instit2">University of Southern California Keck School of Medicine</orgName>
								<orgName type="institution" key="instit3">Good Samaritan Hospital</orgName>
								<address>
									<postCode>90017-1912</postCode>
									<settlement>Los Angeles</settlement>
									<region>CA</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Renate</forename><forename type="middle">B</forename><surname>Alvarez</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Department of Neurology</orgName>
								<orgName type="institution" key="instit1">USC Neuromuscular Center</orgName>
								<orgName type="institution" key="instit2">University of Southern California Keck School of Medicine</orgName>
								<orgName type="institution" key="instit3">Good Samaritan Hospital</orgName>
								<address>
									<postCode>90017-1912</postCode>
									<settlement>Los Angeles</settlement>
									<region>CA</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Valerie</forename><surname>Askanas</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Department of Neurology</orgName>
								<orgName type="institution" key="instit1">USC Neuromuscular Center</orgName>
								<orgName type="institution" key="instit2">University of Southern California Keck School of Medicine</orgName>
								<orgName type="institution" key="instit3">Good Samaritan Hospital</orgName>
								<address>
									<postCode>90017-1912</postCode>
									<settlement>Los Angeles</settlement>
									<region>CA</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<title level="a" type="main">Redox factor-1 in muscle biopsies of patients with inclusion-body myositis</title>
					</analytic>
					<monogr>
						<imprint>
							<date/>
						</imprint>
					</monogr>
					<idno type="MD5">4DA8FD0BBEF3B4B0E1A41746171C5B6B</idno>
					<note type="submission">Received 12 January 2000; accepted 14 March 2000</note>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.7.2" ident="GROBID" when="2023-03-30T18:12+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<textClass>
				<keywords>
					<term>Ref-1</term>
					<term>Inclusion-body myositis</term>
					<term>Muscle diseases</term>
					<term>Regenerating muscle ®bers</term>
					<term>Necrotic muscle ®bers</term>
					<term>Neuromuscular junction</term>
					<term>Oxidative stress Neuroscience Letters 287 (2000) 1±4</term>
				</keywords>
			</textClass>
			<abstract>
<div xmlns="http://www.tei-c.org/ns/1.0"><p>To determine whether redox factor-1 (Ref-1) participates in the pathogenesis of inclusion-body myositis (IBM), we immunolocalized Ref-1 in muscle biopsies of IBM patients by light-and electron-microscopy. Approximately 70±80% of the IBM vacuolated muscle ®bers had focal inclusions strongly immunoreactive for Ref-1. By immunoelectronmicroscopy, Ref-1 was localized to paired-helical ®laments, 6±10 nm amyloid-like ®brils and amorphous material. Virtually all regenerating and necrotic muscle ®bers in various muscle biopsies had diffusely strong Ref-1 immunoreactivity. At all neuromuscular junctions, postsynaptically there was strong Ref-1 immunoreactivity. Our study suggests that Ref-1 plays a role in IBM pathogenesis, and in other pathologic and normal processes of human muscle.</p></div>
			</abstract>
		</profileDesc>
	</teiHeader>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><p>Sporadic inclusion-body myositis (IBM) is the most common, progressive and debilitating muscle disease of older persons (reviewed in <ref type="bibr" target="#b1">[2]</ref>). Pathologic features of IBM muscle biopsies include vacuolated muscle ®bers (VMFs), congo-red positivity (indicating amyloid) within the VMFs, 15±21 nm cytoplasmic paired-helical ®laments (PHFs), and various degree of mononuclear-cell in¯ammation <ref type="bibr" target="#b1">[2]</ref>. A remarkable feature of IBM-VMFs is the presence of a group of proteins that are accumulated in the brain of Alzheimer disease (AD) <ref type="bibr" target="#b1">[2]</ref>. These include amyloid-b precursor protein (AbPP), including its epitope amyloid-b (Ab) <ref type="bibr" target="#b3">[4]</ref>, presenilin-1 <ref type="bibr" target="#b5">[6]</ref>, apolipoprotein E and several other `Alzheimer-characteristic' proteins <ref type="bibr" target="#b1">[2]</ref>. Like in AD brain, IBM muscle PHFs contain phosphorylated tau <ref type="bibr" target="#b10">[11]</ref>, while Ab accumulates in 6±10 nm amyloid-like ®brils <ref type="bibr" target="#b3">[4]</ref>. Oxidative stress, in association with muscle aging, has been postulated to play an important role in IBM pathogenesis <ref type="bibr" target="#b2">[3]</ref>. Markers of oxidative stress in IBM include accumulation within IBM-VMFs of: (1) inducible and neuronal nitric oxide synthases and nitrotyrosine <ref type="bibr" target="#b18">[19]</ref>, (2) malondialdehyde, an indicator of lipid peroxidation <ref type="bibr" target="#b2">[3]</ref>, (3) p50 and p65 components of nuclear factor kB (NF-kB) <ref type="bibr" target="#b19">[20]</ref> and (4) superoxide dismutase 1, seleno-glutathione peroxidase, catalase and their respective mRNAs <ref type="bibr" target="#b2">[3]</ref>.</p><p>Redox factor-1 (Ref-1), also known as APE or HAP1, is a 37 kDa protein possessing apurinic/apyrimidinic endonuclease activity <ref type="bibr" target="#b15">[16,</ref><ref type="bibr" target="#b16">17]</ref>. It is considered to play an important role in gene regulation and DNA repair <ref type="bibr" target="#b16">[17]</ref>. Ref-1 in¯uences gene transcription by regulating the reduction/oxidation state of conserved cysteine residues in the DNAbinding domain of the activator protein-1 (AP-1), a dimeric complex formed by components of the Jun and Fos families of transcription factors <ref type="bibr" target="#b0">[1,</ref><ref type="bibr" target="#b15">16,</ref><ref type="bibr" target="#b16">17]</ref>. Through the reduction of sulfhydryl groups, Ref-1 increases the af®nity of the AP-1 complex to its binding sites in the promoter region of several genes, modulating their transcription <ref type="bibr" target="#b0">[1]</ref>. By a similar mechanism, Ref-1 promotes DNA binding of the transcription factor NF-kB <ref type="bibr" target="#b11">[12]</ref>. Oxidative stress has been shown to induce Ref-1 activation. For example, in vitro, both Ref-1 and its mRNA are induced by reactive oxygen species (ROS) and ROS generators, such as ionizing radiation <ref type="bibr" target="#b13">[14]</ref>. In vivo, in the brain of young rats Ref-1 expression is stimulated by exposure to isobaric hyperoxia <ref type="bibr" target="#b8">[9]</ref>.</p><p>In vivo, by immunocytochemistry, Ref-1 has a different pattern of expression in different cells and organs <ref type="bibr" target="#b7">[8]</ref>. In vitro, in unstimulated cells Ref-1 is located on the inner part of the nuclear membrane and in the cytoplasm <ref type="bibr" target="#b13">[14,</ref><ref type="bibr" target="#b16">17]</ref>. When the cells are stimulated, Ref-1 translocates into the nucleus <ref type="bibr" target="#b13">[14]</ref>. Ref-1 reportedly is present constitutively in a subpopulation of neurons in human brain, and in other organs including skin, liver, and duodenum <ref type="bibr" target="#b7">[8]</ref>. In AD brain, Ref-1 has been immunolocalized in a sub-population of senile plaques, suggesting a functional relationship between Ref-1 and Ab, possibly a role of Ref-1 in Ab accumulation <ref type="bibr" target="#b14">[15]</ref>.</p><p>To determine whether Ref-1 plays a role in IBM pathogenesis, we immunostained, according to our techniques <ref type="bibr" target="#b3">[4,</ref><ref type="bibr" target="#b5">6,</ref><ref type="bibr" target="#b6">7,</ref><ref type="bibr" target="#b10">11]</ref>, 10 mm transverse sections of freshly-frozen diagnostic muscle biopsies from eight IBM patients. We utilized a speci®c rabbit polyclonal antibody against the carboxy terminus epitope of human Ref-1 <ref type="bibr" target="#b9">[10]</ref> (Santa Cruz Biotechnology Inc., Santa Cruz, CA), diluted 1:50. Controls were: muscle biopsies of three peripheral neuropathies, four amyotrophic lateral sclerosis, two myotonic dystrophy, two polymyositis, two dermatomyositis, two morphologically non-speci®c myopathies, one mitochondrial myopathy and three normal patients. Diagnosis was based on clinical and laboratory studies, including our 18-reaction diagnostic histochemistry on muscle biopsies. Double immunolocalization studies utilized polyclonal anti-Ref-1 antibody in combination with either: (1) mouse monoclonal antibody SMI-31 (Sternberger Monoclonals Inc., Baltimore, MD), recognizing phosphorylated tau on IBM-PHFs <ref type="bibr" target="#b10">[11]</ref>  Controls for staining speci®city were: (a) omission of the primary antibody, or (b) its replacement with a non-immune serum or irrelevant antibodies, as described <ref type="bibr" target="#b3">[4,</ref><ref type="bibr" target="#b5">6,</ref><ref type="bibr" target="#b6">7,</ref><ref type="bibr" target="#b10">11]</ref>. To block non-speci®c binding of antibody to Fc receptors, sections were preincubated with normal goat serum diluted 1:10 [4, <ref type="bibr" target="#b5">6,</ref><ref type="bibr" target="#b6">7,</ref><ref type="bibr" target="#b10">11]</ref>.</p><p>Immuno-electronmicroscopy (immuno-EM) was performed as described previously <ref type="bibr" target="#b3">[4,</ref><ref type="bibr" target="#b5">6,</ref><ref type="bibr" target="#b10">11]</ref>.</p><p>In all muscle biopsies, Ref-1 was immunolocalized along the myonuclear membrane and was slightly more strongly expressed in type-II than in type-I muscle ®bers.</p><p>By light microscopy, approximately 70±80% of IBM-VMFs, and some of the non-VMFs, had Ref-1 immunoreactivity in the form of squiggly, linear, and plaquette-like inclusions (Fig. <ref type="figure" target="#fig_0">1</ref>). Ref-1 immunoreactive inclusions colocalized with SMI-31 and Ab immunoreactivity (Fig. <ref type="figure" target="#fig_0">1</ref>).</p><p>By immuno-EM utilizing horseradish peroxidase, Ref-1 was localized to the PHFs, covering them entirely (Fig. <ref type="figure" target="#fig_4">2A</ref>). By gold-immuno-EM, Ref-1 was mostly attached to the PHFs by very thin, short threads (Fig. <ref type="figure" target="#fig_4">2B</ref>). Ref-1 was also localized to 6±10 nm amyloid-like ®brils and to amorphous material (Fig. <ref type="figure" target="#fig_4">2C</ref>).</p><p>In all myopathies, regenerating and necrotic muscle ®bers had strong and diffuse Ref-1 immunoreactivity (Fig. <ref type="figure" target="#fig_3">3</ref>). Double labeling with the macrophage marker Ber MAC3 showed that in necrotic ®bers Ref-1 immunoreactivity did not co-localize with the Ber MAC3 immunoreactivity.</p><p>In all muscle biopsies, Ref-1 immunoreactivity was present at the postsynaptic domain of the neuromuscular junctions (NMJs), where it co-localized with bound abungarotoxin (Fig. <ref type="figure" target="#fig_3">3</ref>). However, immunoreactivity for Ref-1 appeared slightly wider and deeper in the ®ber than the area occupied by bound a-bungarotoxin.</p><p>Either omitting the primary antiserum or its replacement with non-immune or irrelevant antisera produced negative results.</p><p>Our study demonstrates for the ®rst time that Ref-1 participates in pathologic processes affecting human skeletal muscle. In IBM, overexpression of Ref-1 may: (a) result from oxidative stress, markers of which we have previously demonstrated; and (b) be functionally related to the overexpression of transcription factor NF-kB <ref type="bibr" target="#b19">[20]</ref>. For example, in vitro, Ref-1 stimulates the DNA-binding activity of a recombinant p50 component of NF-kB <ref type="bibr" target="#b11">[12]</ref>. Accordingly, in IBM Ref-1 might modulate the DNA-binding activity of NF-kB, and possibly of other transcription factors, such as AP-1. c-Jun and c-Fos components of the AP-1 complex appear to be increased in IBM muscle ®bers <ref type="bibr">(Broccolini and Askanas, 1999</ref>, unpublished observation). The promoter region of the AbPP gene contains speci®c recognition sequences for transcription factors NF-kB and AP-1 <ref type="bibr" target="#b12">[13]</ref>, and AbPP mRNA is increased in IBM-VMFs <ref type="bibr" target="#b1">[2,</ref><ref type="bibr" target="#b2">3]</ref>. This mechanism might be involved in the increased AbPP gene transcription in IBM.</p><p>In IBM abnormal muscle ®bers, Ref-1 immunolocalizes to (a) PHFs containing phosphorylated tau and (b) 6±10 nm amyloid-like ®brils and amorphous material, both containing Ab.</p><p>Because Ref-1 immunoreactivity appears to be attached to the PHFs by thin threads, it is possible that this results from its association with another PHFs-binding protein.</p><p>Proteins related to oxidative stress that are present on IBM-PHFs include nitrotyrosine and NF-kB <ref type="bibr" target="#b18">[19,</ref><ref type="bibr" target="#b19">20]</ref>. Moreover, IBM-PHFs contain RNA and the RNA-binding protein, survival motor neuron (SMN) <ref type="bibr" target="#b6">[7]</ref>. Therefore, the presence of Ref-1 on IBM-PHFs might be related to its role in either oxidative stress or in aberrant transcription, or both.</p><p>Ref It has been previously demonstrated that Ref-1 expression is developmentally regulated <ref type="bibr" target="#b17">[18]</ref>. However, its possible role in cellular development and regeneration is not yet  </p></div><figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_0"><head>diluted 1 :</head><label>1</label><figDesc>1000; (2) mouse monoclonal antibody 6E10, recognizing aminoacid residues 1±17 of human amyloid-b peptide (Senetek, Maryland Heights, MO) diluted 1:100; (3) mouse monoclonal antibody against desmin (Zymed, San Francisco, CA) diluted 1:20, which is highly expressed in human regenerating muscle ®bers; or (4) mouse monoclonal antibody against human macrophages (clone Ber MAC3, DAKO, Carpenteria, CA) diluted 1:10. The postsynaptic domain of neuromuscular junctions (NMJs) was visualized by the binding of a-bungarotoxin conjugated with Alexae ¯uorochrome (Molecular Probes, Eugene, OR).</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_1"><head>Fig. 1 .</head><label>1</label><figDesc>Fig. 1. Double label immuno¯uorescence illustrating close colocalization between Ref-1 and SMI31 (A,B) and Ref-1 and Ab (C,D). £900.</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_2"><head></head><label></label><figDesc>-1 co-localization with Ab immunoreactivity and its presence on Ab-containing amyloid-like ®brils in IBM may indicate that (a) Ref-1 participates in Ab deposition, or (b) accumulated Ab induces oxidative stress leading to induction of Ref-1.</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_3"><head>Fig. 3 .</head><label>3</label><figDesc>Fig. 3. Double label immuno¯uorescence. (A,B) Regenerating muscle ®bers. Ref-1 (A) is strongly expressed in two, highlighted by desmin (B), regenerating muscle ®bers. (C) Ref-1 immunoreactive necrotic muscle ®ber is desmin negative (D). (E,F) Two normal neuromuscular junctions. E, Ref-1; F, a-bungarotoxin (a-BT) bound to the postsynaptic nicotinic acetylcholine receptor. There is a colocalization between Ref-1 and a-BT, with Ref-1 seeming to occupy a slightly larger territory. £800.</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_4"><head>Fig. 2 .</head><label>2</label><figDesc>Fig. 2. Immunoelectronmicroscopy. (A) Low magni®cation of horseradish-peroxidase staining illustrating localization of Ref-1 to paired helical ®laments. An adjacent portion of the myo®ber (below) is not immunostained. (B,C) Gold immunostaining using 5 nm gold particles. In (B) Ref-1 is localized to paired helical ®laments, while in (C) gold particles are localized to amorphous material and 6±10 nm amyloid-like ®brils. (A) £11 000; (B,C) £110 000. Bars represent 1 mm in (A) and 0.1 mm in (B,C).</figDesc></figure>
		</body>
		<back>

			<div type="acknowledgement">
<div xmlns="http://www.tei-c.org/ns/1.0"><p>understood. The increased expression of Ref-1 in regenerating muscle ®bers suggests its possible role in human muscle growth and development.</p><p>The cause of Ref-1 overexpression in human necrotic ®bers and its role in muscle-®ber necrosis are not known. Since NF-kB is also upregulated in human necrotic muscle ®bers <ref type="bibr" target="#b19">[20]</ref>, the possibility exists that the same stimulatory mechanism, for example oxidative stress that is probably present in necrotic muscle ®bers, may upregulate both Ref-1 and NF-kB.</p><p>Our novel localization of Ref-1 at the postsynaptic domain of human NMJs suggests that Ref-1 may in¯uence transcription of genes there such as AbPP. Postsynaptic accumulation of at least 14 proteins and the mRNAs of some of them, including AbPP, has been shown at human NMJs <ref type="bibr" target="#b4">[5]</ref>.</p><p>Supported in part by grants from the NIH (NS 34103 and AG 16768) and the Muscular Dystrophy Association (to V.A.). A.B. is a postdoctoral research fellow in Dr Askanas' laboratory. Maggie Baburyan provided excellent assistance in electronmicroscopy and photography.</p></div>
			</div>

			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<analytic>
		<title level="a" type="main">Redox regulation of Fos and Jun DNA-binding activity in vitro</title>
		<author>
			<persName><forename type="first">C</forename><surname>Abate</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Patel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Iii</forename><surname>Rauscher</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">J</forename><surname>Curran</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Science</title>
		<imprint>
			<biblScope unit="page" from="1157" to="1161" />
			<date type="published" when="1990">1990</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b1">
	<analytic>
		<title level="a" type="main">Sporadic inclusion-body myositis and its similarities to Alzheimer disease brain. Recent approaches to diagnosis and pathogenesis, and relation to aging</title>
		<author>
			<persName><forename type="first">V</forename><surname>Askanas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">K</forename><surname>Engel</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Scand. J. Rheumatol</title>
		<imprint>
			<biblScope unit="volume">27</biblScope>
			<biblScope unit="page" from="389" to="405" />
			<date type="published" when="1998">1998</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b2">
	<analytic>
		<title level="a" type="main">Sporadic inclusion-body myositis and hereditary inclusion-body myopathies. Diseases of oxidative stress and aging?</title>
		<author>
			<persName><forename type="first">V</forename><surname>Askanas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">K</forename><surname>Engel</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Arch. Neurol</title>
		<imprint>
			<biblScope unit="volume">55</biblScope>
			<biblScope unit="page" from="915" to="920" />
			<date type="published" when="1998">1998</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b3">
	<analytic>
		<title level="a" type="main">b-amyloid precursor epitopes in muscle ®bers of inclusion-body myositis</title>
		<author>
			<persName><forename type="first">V</forename><surname>Askanas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">B</forename><surname>Alvarez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">K</forename><surname>Engel</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Ann. Neurol</title>
		<imprint>
			<biblScope unit="volume">34</biblScope>
			<biblScope unit="page" from="551" to="560" />
			<date type="published" when="1993">1993</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b4">
	<analytic>
		<title level="a" type="main">Fourteen newly recognized proteins at the human neuromuscular junctions and their non-junctional accumulation in inclusion-body myositis</title>
		<author>
			<persName><forename type="first">V</forename><surname>Askanas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">K</forename><surname>Engel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">B</forename><surname>Alvarez</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Ann. N.Y. Acad. Sci</title>
		<editor>D.P. Richman</editor>
		<imprint>
			<biblScope unit="volume">841</biblScope>
			<biblScope unit="page" from="28" to="56" />
			<date type="published" when="1998">1998</date>
		</imprint>
	</monogr>
	<note>Myasthenia Gravis and Related Diseases: Disorders of the Neuromuscular Junction</note>
</biblStruct>

<biblStruct xml:id="b5">
	<analytic>
		<title level="a" type="main">Light and electron microscopic immunolocalization of presenilin 1 in abnormal muscle ®bers of patients with sporadic inclusion-body myositis and autosomal-recessive inclusion-body myopathy</title>
		<author>
			<persName><forename type="first">V</forename><surname>Askanas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">K</forename><surname>Engel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">C</forename><surname>Yang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">B</forename><surname>Alvarez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><forename type="middle">M</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Wisniewski</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am. J. Pathol</title>
		<imprint>
			<biblScope unit="volume">152</biblScope>
			<biblScope unit="page" from="889" to="895" />
			<date type="published" when="1998">1998</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b6">
	<analytic>
		<title level="a" type="main">Paired-helical ®laments of inclusion-body myositis muscle contain RNA and survival motor neuron protein</title>
		<author>
			<persName><forename type="first">A</forename><surname>Broccolini</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">K</forename><surname>Engel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">B</forename><surname>Alvarez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Askanas</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am. J. Pathol. Ann. N.Y. Acad. Sci</title>
		<imprint>
			<biblScope unit="volume">156</biblScope>
			<biblScope unit="page" from="1151" to="1155" />
			<date type="published" when="2000">2000</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b7">
	<analytic>
		<title level="a" type="main">Differential cellular and subcellular expression of the human multifunctional apurinic/apyrimidinic endonuclease (APE/Ref-1) DNA repair enzyme</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">R</forename><surname>Duguid</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">N</forename><surname>Eble</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">M</forename><surname>Wilson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">R</forename><surname>Kelley</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cancer Res</title>
		<imprint>
			<biblScope unit="volume">55</biblScope>
			<biblScope unit="page" from="6097" to="6102" />
			<date type="published" when="1995">1995</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b8">
	<analytic>
		<title level="a" type="main">APE/Ref-1 responses to oxidative stress in aged rats</title>
		<author>
			<persName><forename type="first">M</forename><surname>Edwards</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">K</forename><surname>Rassin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Tadahide</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Mitra</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">R</forename><surname>Perez-Polo</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Neurosci. Res</title>
		<imprint>
			<biblScope unit="volume">54</biblScope>
			<biblScope unit="page" from="635" to="638" />
			<date type="published" when="1998">1998</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b9">
	<analytic>
		<title level="a" type="main">AP-1 transcriptional activity is regulated by a direct association between thioredoxin and Ref-1</title>
		<author>
			<persName><forename type="first">K</forename><surname>Hirota</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Matsui</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Iwata</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Nishiyama</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Mori</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Yodoi</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Proc. Natl. Acad. Sci. USA</title>
		<imprint>
			<biblScope unit="volume">94</biblScope>
			<biblScope unit="page" from="3633" to="3638" />
			<date type="published" when="1997">1997</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b10">
	<analytic>
		<title level="a" type="main">Difference in expression of phosphorylated tau epitopes between sporadic inclusion-body myositis and hereditary inclusion-body myopathies</title>
		<author>
			<persName><forename type="first">M</forename><surname>Mirabella</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">B</forename><surname>Alvarez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Bilak</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">K</forename><surname>Engel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Askanas</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Neuropathol. Exp. Neurol</title>
		<imprint>
			<biblScope unit="volume">55</biblScope>
			<biblScope unit="page" from="774" to="786" />
			<date type="published" when="1996">1996</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b11">
	<analytic>
		<title level="a" type="main">Two different cellular redox systems regulate the DNA-binding activity of the p50 subunit of NF-kB in vitro</title>
		<author>
			<persName><forename type="first">K</forename><surname>Mitomo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Nakayama</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Fujimoto</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><surname>Sun</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Seki</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Yamamoto</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Gene</title>
		<imprint>
			<biblScope unit="volume">145</biblScope>
			<biblScope unit="page" from="197" to="203" />
			<date type="published" when="1994">1994</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b12">
	<analytic>
		<title level="a" type="main">The amyloid b-protein precursor promoter, A region essential for transcriptional activity contains a nuclear factor binding domain</title>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">W</forename><surname>Quitschke</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Goldgaber</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Biol. Chem</title>
		<imprint>
			<biblScope unit="volume">267</biblScope>
			<biblScope unit="page" from="17362" to="17368" />
			<date type="published" when="1992">1992</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b13">
	<analytic>
		<title level="a" type="main">Activation of apurinic/apyrimidinic endonuclease in human cells by reactive oxygen species and its correlation with their adaptive response to genotoxicity of free radicals</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">V</forename><surname>Ramana</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Boldogh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Izumi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Mitra</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="m">Proc. Natl. Acad. Sci. USA</title>
				<meeting>Natl. Acad. Sci. USA</meeting>
		<imprint>
			<date type="published" when="1998">1998</date>
			<biblScope unit="volume">95</biblScope>
			<biblScope unit="page" from="5061" to="5066" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b14">
	<analytic>
		<title level="a" type="main">Immunohistochemical localization of redox factor-1 (Ref-1) in Alzheimer&apos;s hippocampus</title>
		<author>
			<persName><forename type="first">Z</forename><surname>Tan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Sun</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">S</forename><surname>Schreiber</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">NeuroReport</title>
		<imprint>
			<biblScope unit="volume">9</biblScope>
			<biblScope unit="page" from="2749" to="2752" />
			<date type="published" when="1998">1998</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b15">
	<analytic>
		<title level="a" type="main">Identi®cation and characterization of Ref-1, a nuclear protein that facilitates AP-1 DNA-binding activity</title>
		<author>
			<persName><forename type="first">S</forename><surname>Xanthoudakis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Curran</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">EMBO J</title>
		<imprint>
			<biblScope unit="volume">11</biblScope>
			<biblScope unit="page" from="653" to="665" />
			<date type="published" when="1992">1992</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b16">
	<analytic>
		<title level="a" type="main">Redox activation of Fos-Jun DNA binding activity is mediated by a DNA repair enzyme</title>
		<author>
			<persName><forename type="first">S</forename><surname>Xanthoudakis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Miao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><forename type="middle">C E</forename><surname>Pan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Curran</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">EMBO J</title>
		<imprint>
			<biblScope unit="volume">11</biblScope>
			<biblScope unit="page" from="3323" to="3335" />
			<date type="published" when="1992">1992</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b17">
	<analytic>
		<title level="a" type="main">Differential expression of the apurinic/apyrimidinic endonuclease (APE/Ref-1) multifunctional DNA base excision repair gene during fetal development and in adult rat brain and testis</title>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">M</forename><surname>Wilson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">A</forename><surname>Rivkees</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">A</forename><surname>Deutsch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">R</forename><surname>Kelley</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Mutat. Res</title>
		<imprint>
			<biblScope unit="volume">362</biblScope>
			<biblScope unit="page" from="237" to="248" />
			<date type="published" when="1996">1996</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b18">
	<analytic>
		<title level="a" type="main">Increase of nitric oxide synthases and nitrotyrosine in inclusion-body myositis</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">C</forename><surname>Yang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">B</forename><surname>Alvarez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">K</forename><surname>Engel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Askanas</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">NeuroReport</title>
		<imprint>
			<biblScope unit="volume">8</biblScope>
			<biblScope unit="page" from="153" to="158" />
			<date type="published" when="1996">1996</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b19">
	<analytic>
		<title level="a" type="main">Immunolocalization of transcription factor NF-kB in inclusion-body myositis muscle and at normal human neuromuscular junctions</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">C</forename><surname>Yang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Askanas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">K</forename><surname>Engel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">B</forename><surname>Alvarez</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neurosci. Lett</title>
		<imprint>
			<biblScope unit="volume">254</biblScope>
			<biblScope unit="page" from="77" to="80" />
			<date type="published" when="1998">1998</date>
		</imprint>
	</monogr>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
